Loading clinical trials...
Loading clinical trials...
Hypothesis: By blocking aldosterone signaling in patients with Tetralogy of Fallot, Transposition of the great vessels with a prior atrial switch, and single ventricle "Fontan" patients, incident hea...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Washington University School of Medicine
Collaborators
NCT06932081 · Adult Congenital Heart Disease, Congenital Heart Disease, and more
NCT06771687 · Congenital Heart Disease, Truncus Arteriosus, and more
NCT04713657 · Tetralogy of Fallot, Double Outlet Right Ventricle
NCT04106479 · Congenital Heart Defect, Single-ventricle, and more
NCT00243776 · Congenital Heart Disease, Tetralogy of Fallot
Washington University School of Medicine
St Louis, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions